-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Praxis Precision Medicine, Raises Price Target to $1050

Benzinga·11/16/2026 14:11:07
Guggenheim analyst Yatin Suneja maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $800 to $1050.